XML 27 R15.htm IDEA: XBRL DOCUMENT

CONCENTRATION OF RISK	9 Months Ended
CONCENTRATION OF RISK	Sep. 30, 2016
Risks and Uncertainties [Abstract]
Concentration of Risk	CONCENTRATION OF RISK Customer and Credit Risk The Company provides trade credit to its customers in the normal course of business. One commercial payor, United Healthcare, accounted for approximately 24.0% and 25.0% of revenue during the three months ended September 30, 2016 and 2015, respectively, and approximately 24.9% and 24.0% of revenue during the nine months ended September 30, 2016 and 2015, respectively. In addition, Medicare accounted for approximately 10.5% and 9.6% of revenue during the three months ended September 30, 2016 and 2015, respectively, and approximately 10.6% and 9.9% of revenue during the nine months ended September 30, 2016 and 2015, respectively. Therapy Revenue Risk The Company sells products related to the Immune Globulin therapy, which represented 19.1% and 17.0% of revenue for the three months ended September 30, 2016 and 2015, respectively, and 17.8% and 16.9% of revenue during the nine months ended September 30, 2016 and 2015, respectively.